Annual Net Income
-$15.18 M
-$3.45 M-29.38%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual net profit is currently -$15.18 million, with the most recent change of -$3.45 million (-29.38%) on 31 December 2022. During the last 3 years, it has fallen by -$4.46 million (-41.56%). NAVB annual net income is now -120.25% below its all-time high of $74.95 million, reached on 31 December 2017.NAVB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.26 M
-$8.29 M-137.39%
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly net profit is currently -$2.26 million, with the most recent change of -$8.29 million (-137.39%) on 30 September 2023. NAVB quarterly net income is now -102.64% below its all-time high of $85.58 million, reached on 31 March 2017.NAVB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$1.18 M
+$3.45 M+74.49%
30 September 2023
Summary:
Navidea Biopharmaceuticals TTM net profit is currently -$1.18 million, with the most recent change of +$3.45 million (+74.49%) on 30 September 2023. NAVB TTM net income is now -101.55% below its all-time high of $76.45 million, reached on 30 June 2017.NAVB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -41.6% | +7.5% | +89.2% |
| 5 y5 years | +5.8% | +26.6% | +89.6% |
NAVB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.6% | at low | -137.4% | +60.5% | at high | +92.3% |
| 5 y | 5 years | -41.6% | +5.8% | -137.4% | +60.5% | at high | +92.3% |
| alltime | all time | -120.3% | +69.6% | -102.6% | +94.8% | -101.5% | +98.3% |
Navidea Biopharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$2.26 M(-137.4%) | -$1.18 M(-74.5%) |
| June 2023 | - | $6.03 M(-508.6%) | -$4.63 M(-66.1%) |
| Mar 2023 | - | -$1.48 M(-57.6%) | -$13.67 M(-10.0%) |
| Dec 2022 | -$15.18 M(+29.4%) | -$3.48 M(-39.0%) | -$15.18 M(-1.1%) |
| Sept 2022 | - | -$5.71 M(+90.3%) | -$15.35 M(+27.1%) |
| June 2022 | - | -$3.00 M(+0.4%) | -$12.08 M(+2.8%) |
| Mar 2022 | - | -$2.99 M(-18.2%) | -$11.75 M(+0.2%) |
| Dec 2021 | -$11.73 M(+9.4%) | -$3.65 M(+49.8%) | -$11.73 M(+7.6%) |
| Sept 2021 | - | -$2.44 M(-8.8%) | -$10.90 M(-4.1%) |
| June 2021 | - | -$2.67 M(-9.9%) | -$11.36 M(+3.2%) |
| Mar 2021 | - | -$2.97 M(+5.1%) | -$11.01 M(+2.7%) |
| Dec 2020 | -$10.72 M(-2.1%) | -$2.82 M(-2.6%) | -$10.72 M(+0.5%) |
| Sept 2020 | - | -$2.90 M(+24.7%) | -$10.67 M(-1.6%) |
| June 2020 | - | -$2.33 M(-13.0%) | -$10.85 M(-3.1%) |
| Mar 2020 | - | -$2.67 M(-3.5%) | -$11.19 M(+2.2%) |
| Dec 2019 | -$10.95 M(-32.1%) | -$2.77 M(-9.8%) | -$10.95 M(-3.4%) |
| Sept 2019 | - | -$3.07 M(+15.0%) | -$11.34 M(-6.2%) |
| June 2019 | - | -$2.67 M(+10.1%) | -$12.08 M(+2.4%) |
| Mar 2019 | - | -$2.43 M(-23.1%) | -$11.80 M(-26.7%) |
| Dec 2018 | -$16.11 M(-121.5%) | -$3.16 M(-17.3%) | -$16.11 M(-5.3%) |
| Sept 2018 | - | -$3.82 M(+59.6%) | -$17.01 M(+16.7%) |
| June 2018 | - | -$2.39 M(-64.5%) | -$14.58 M(-16.1%) |
| Mar 2018 | - | -$6.74 M(+66.0%) | -$17.37 M(-123.2%) |
| Dec 2017 | $74.95 M(-623.8%) | -$4.06 M(+192.1%) | $74.95 M(-0.2%) |
| Sept 2017 | - | -$1.39 M(-73.2%) | $75.12 M(-1.7%) |
| June 2017 | - | -$5.19 M(-106.1%) | $76.45 M(+2.0%) |
| Mar 2017 | - | $85.58 M(-2304.7%) | $74.96 M(-623.9%) |
| Dec 2016 | -$14.31 M(-48.1%) | -$3.88 M(+6435.0%) | -$14.31 M(+10.6%) |
| Sept 2016 | - | -$59.40 K(-99.1%) | -$12.94 M(-38.2%) |
| June 2016 | - | -$6.68 M(+81.3%) | -$20.95 M(-12.6%) |
| Mar 2016 | - | -$3.69 M(+46.8%) | -$23.96 M(-13.1%) |
| Dec 2015 | -$27.56 M(-22.9%) | -$2.51 M(-68.9%) | -$27.56 M(-13.6%) |
| Sept 2015 | - | -$8.07 M(-16.7%) | -$31.92 M(+3.8%) |
| June 2015 | - | -$9.69 M(+32.9%) | -$30.75 M(-1.7%) |
| Mar 2015 | - | -$7.29 M(+6.2%) | -$31.28 M(-12.5%) |
| Dec 2014 | -$35.73 M(-16.3%) | -$6.87 M(-0.5%) | -$35.73 M(-16.2%) |
| Sept 2014 | - | -$6.90 M(-32.5%) | -$42.61 M(-9.4%) |
| June 2014 | - | -$10.22 M(-12.9%) | -$47.02 M(-0.2%) |
| Mar 2014 | - | -$11.74 M(-14.6%) | -$47.10 M(+10.3%) |
| Dec 2013 | -$42.70 M(+46.4%) | -$13.75 M(+21.6%) | -$42.70 M(+18.0%) |
| Sept 2013 | - | -$11.31 M(+9.8%) | -$36.18 M(+6.5%) |
| June 2013 | - | -$10.30 M(+40.3%) | -$33.97 M(+15.1%) |
| Mar 2013 | - | -$7.34 M(+1.5%) | -$29.51 M(+1.2%) |
| Dec 2012 | -$29.16 M(-619.5%) | -$7.23 M(-20.5%) | -$29.16 M(-1.3%) |
| Sept 2012 | - | -$9.10 M(+55.9%) | -$29.53 M(+4822.6%) |
| June 2012 | - | -$5.83 M(-16.5%) | -$599.90 K(-119.7%) |
| Mar 2012 | - | -$6.99 M(-8.1%) | $3.05 M(-45.7%) |
| Dec 2011 | $5.61 M(-111.2%) | -$7.61 M(-138.4%) | $5.61 M(-49.7%) |
| Sept 2011 | - | $19.83 M(-1006.0%) | $11.17 M(-201.1%) |
| June 2011 | - | -$2.19 M(-50.5%) | -$11.05 M(-78.7%) |
| Mar 2011 | - | -$4.42 M(+115.4%) | -$51.93 M(+3.9%) |
| Dec 2010 | -$49.96 M(+26.2%) | -$2.05 M(-13.8%) | -$49.96 M(+3.7%) |
| Sept 2010 | - | -$2.38 M(-94.5%) | -$48.21 M(-31.9%) |
| June 2010 | - | -$43.07 M(+1650.7%) | -$70.83 M(+65.2%) |
| Mar 2010 | - | -$2.46 M(+737.9%) | -$42.88 M(+8.3%) |
| Dec 2009 | -$39.61 M(+666.6%) | -$293.60 K(-98.8%) | -$39.61 M(-2.3%) |
| Sept 2009 | - | -$25.01 M(+65.4%) | -$40.54 M(+132.7%) |
| June 2009 | - | -$15.12 M(-1956.9%) | -$17.42 M(+423.8%) |
| Mar 2009 | - | $814.10 K(-166.1%) | -$3.33 M(-35.6%) |
| Dec 2008 | -$5.17 M | -$1.23 M(-34.9%) | -$5.17 M(-11.5%) |
| Sept 2008 | - | -$1.89 M(+85.6%) | -$5.84 M(+19.4%) |
| June 2008 | - | -$1.02 M(-0.7%) | -$4.89 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$1.03 M(-46.0%) | -$5.00 M(-1.7%) |
| Dec 2007 | -$5.09 M(+7.3%) | -$1.90 M(+101.8%) | -$5.09 M(+13.5%) |
| Sept 2007 | - | -$941.80 K(-17.0%) | -$4.48 M(-13.7%) |
| June 2007 | - | -$1.13 M(+2.1%) | -$5.20 M(+5.5%) |
| Mar 2007 | - | -$1.11 M(-14.3%) | -$4.92 M(+3.9%) |
| Dec 2006 | -$4.74 M(-3.8%) | -$1.30 M(-21.8%) | -$4.74 M(-0.0%) |
| Sept 2006 | - | -$1.66 M(+92.3%) | -$4.74 M(+8.5%) |
| June 2006 | - | -$861.50 K(-7.1%) | -$4.37 M(-9.9%) |
| Mar 2006 | - | -$927.60 K(-28.5%) | -$4.85 M(-1.5%) |
| Dec 2005 | -$4.93 M(+39.2%) | -$1.30 M(+1.0%) | -$4.93 M(-16.7%) |
| Sept 2005 | - | -$1.28 M(-4.5%) | -$5.92 M(+21.5%) |
| June 2005 | - | -$1.34 M(+34.1%) | -$4.87 M(+23.1%) |
| Mar 2005 | - | -$1.00 M(-56.1%) | -$3.96 M(+11.7%) |
| Dec 2004 | -$3.54 M(+96.8%) | -$2.28 M(+856.4%) | -$3.54 M(+92.5%) |
| Sept 2004 | - | -$238.80 K(-44.5%) | -$1.84 M(-18.6%) |
| June 2004 | - | -$429.90 K(-27.0%) | -$2.26 M(+18.4%) |
| Mar 2004 | - | -$588.60 K(+1.2%) | -$1.91 M(+6.1%) |
| Dec 2003 | -$1.80 M(-39.3%) | -$581.90 K(-11.7%) | -$1.80 M(+30.2%) |
| Sept 2003 | - | -$659.10 K(+730.1%) | -$1.38 M(-23.5%) |
| June 2003 | - | -$79.40 K(-83.4%) | -$1.81 M(-30.5%) |
| Mar 2003 | - | -$478.60 K(+190.6%) | -$2.60 M(-12.4%) |
| Dec 2002 | -$2.96 M(<-9900.0%) | -$164.70 K(-84.8%) | -$2.96 M(-13.9%) |
| Sept 2002 | - | -$1.08 M(+24.3%) | -$3.44 M(+75.7%) |
| June 2002 | - | -$871.20 K(+3.1%) | -$1.96 M(+115.1%) |
| Mar 2002 | - | -$845.10 K(+31.1%) | -$911.20 K(-6174.7%) |
| Dec 2001 | $15.00 K(-99.2%) | -$644.80 K(-260.7%) | $15.00 K(-98.9%) |
| Sept 2001 | - | $401.30 K(+126.2%) | $1.38 M(-6.9%) |
| June 2001 | - | $177.40 K(+118.7%) | $1.49 M(-23.7%) |
| Mar 2001 | - | $81.10 K(-88.8%) | $1.95 M(+5.9%) |
| Dec 2000 | $1.84 M(-144.1%) | $723.40 K(+43.5%) | $1.84 M(+64.8%) |
| Sept 2000 | - | $504.10 K(-21.1%) | $1.12 M(+82.3%) |
| June 2000 | - | $639.30 K(-2476.6%) | $612.40 K(-142.9%) |
| Mar 2000 | - | -$26.90 K(-98.1%) | -$1.43 M(-92.2%) |
| Dec 1999 | -$4.17 M(-85.1%) | - | - |
| June 1999 | - | -$1.40 M(+7.7%) | -$18.33 M(-17.5%) |
| Mar 1999 | - | -$1.30 M(-87.0%) | -$22.23 M(-20.7%) |
| Dec 1998 | -$28.03 M(+20.6%) | -$10.03 M(+79.2%) | -$28.03 M(+17.6%) |
| Sept 1998 | - | -$5.60 M(+5.7%) | -$23.85 M(+0.8%) |
| June 1998 | - | -$5.30 M(-25.4%) | -$23.65 M(-7.4%) |
| Mar 1998 | - | -$7.10 M(+21.4%) | -$25.55 M(+10.4%) |
| Dec 1997 | -$23.25 M(+10.7%) | -$5.85 M(+8.3%) | -$23.15 M(-11.3%) |
| Sept 1997 | - | -$5.40 M(-25.0%) | -$26.10 M(+4.8%) |
| June 1997 | - | -$7.20 M(+53.2%) | -$24.90 M(+12.7%) |
| Mar 1997 | - | -$4.70 M(-46.6%) | -$22.10 M(+5.2%) |
| Dec 1996 | -$21.00 M(+94.4%) | -$8.80 M(+109.5%) | -$21.00 M(+35.5%) |
| Sept 1996 | - | -$4.20 M(-4.5%) | -$15.50 M(+12.3%) |
| June 1996 | - | -$4.40 M(+22.2%) | -$13.80 M(+16.0%) |
| Mar 1996 | - | -$3.60 M(+9.1%) | -$11.90 M(+10.2%) |
| Dec 1995 | -$10.80 M(0.0%) | -$3.30 M(+32.0%) | -$10.80 M(+4.9%) |
| Sept 1995 | - | -$2.50 M(0.0%) | -$10.30 M(-7.2%) |
| June 1995 | - | -$2.50 M(0.0%) | -$11.10 M(+4.7%) |
| Mar 1995 | - | -$2.50 M(-10.7%) | -$10.60 M(-0.9%) |
| Dec 1994 | -$10.80 M(+35.0%) | -$2.80 M(-15.2%) | -$10.70 M(+2.9%) |
| Sept 1994 | - | -$3.30 M(+65.0%) | -$10.40 M(+11.8%) |
| June 1994 | - | -$2.00 M(-23.1%) | -$9.30 M(0.0%) |
| Mar 1994 | - | -$2.60 M(+4.0%) | -$9.30 M(+16.3%) |
| Dec 1993 | -$8.00 M(+207.7%) | -$2.50 M(+13.6%) | -$8.00 M(+27.0%) |
| Sept 1993 | - | -$2.20 M(+10.0%) | -$6.30 M(+26.0%) |
| June 1993 | - | -$2.00 M(+53.8%) | -$5.00 M(+66.7%) |
| Mar 1993 | - | -$1.30 M(+62.5%) | -$3.00 M(+76.5%) |
| Dec 1992 | -$2.60 M | -$800.00 K(-11.1%) | -$1.70 M(+88.9%) |
| Sept 1992 | - | -$900.00 K | -$900.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual net profit?
- What is the all time high annual net income for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals TTM net profit?
- What is the all time high TTM net income for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual net profit?
The current annual net income of NAVB is -$15.18 M
What is the all time high annual net income for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual net profit is $74.95 M
What is Navidea Biopharmaceuticals quarterly net profit?
The current quarterly net income of NAVB is -$2.26 M
What is the all time high quarterly net income for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly net profit is $85.58 M
What is Navidea Biopharmaceuticals TTM net profit?
The current TTM net income of NAVB is -$1.18 M
What is the all time high TTM net income for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM net profit is $76.45 M